Ameriprise’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Ameriprise’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,728	Closed	-$1.96M	–	4032
2016 Q3	$1.96M	Buy	+48,728	New	+$1.2M	﹤0.01%	2576

Ameriprise's CYNA Position: Q4 2016 in Review

Ameriprise sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 48,728 shares — an estimated $1.96M sold.

Ameriprise first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $1.96M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Ameriprise reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Ameriprise sold 48,728 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $1.96M.
Ameriprise first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
Ameriprise's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $1.96M in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Ameriprise's 13F filing for Q4 2016, filed 3 Feb 2017.